Incyte nears $2B deal for blood disorder drug developer Star Therapeutics: FT

The S&P 500 Is Up 9% in 2026. Wall Street Says the Stock Market Will Do This Next.

2026/06/24

How Micron stacks up against major chip peers ahead of earnings

2026/06/24

1 Services Stock to Target This Week and 2 We Find Risky

2026/06/24

Bilibili sets $300M stock buyback plan

2026/06/24